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“ In all things of nature there is something of the marvellous. “ 
Aris totle, 384-322 B.C. 
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Abbreviations and symbols 
UQ  ubiquinone 
UQ·  semiquinone 
UQH2 ubiquinol 
DmH+  electrochemical proton gradient 
e-  electron 
redox  reduction and oxidation 
EXAFS extended X-ray absorption fine structure 
ENDOR electron-nuclear double resonance 
FTIR  Fourier transform infrared 
PMF  potentials of mean force 
KM  Michaelis constant 
Em  redox midpoint potential 
RT  room temperature 
Fea3, Feo3 iron of the ligand-binding heme 
Fea  low-spin heme iron 
CuA  copper site in subunit II 
CuB  copper of the binuclear site 
Kd  dissociation constant 
IN   indicates the matrix space in mitochondria and cytosol in bacteria  
OUT         indicates the intermembrane space in mitochondria and periplasmic space in 
bacteria. 
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The numbering of amino acid residues in this work mainly refers to the P. denitrificans enzyme. E. 
coli amino acid numbers are used when specifically discussing the cytochrome bo3 mutant enzymes. 
The number of the corresponding amino acid in the bovine cytochrome c oxidase is given in brackets. 
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1. Introduction 
 
Food contains protein, carbohydrates and fat that must be broken down into smaller molecules before 
individual cells can use them as a source of energy (Fig. 1). Initially, these large molecules are broken 
down into their monomeric subunits, such as simple sugars, amino acids and fatty acids. This process 
is called digestion, and it occurs mainly outside the cell by secreted digestive enzymes. The resulting 
small molecules are transported into the cell where they are converted into the acetyl unit of acetyl 
CoA. The acetyl group enters the citric acid cycle where it is completely oxidized to CO2 and the 
electrons are transferred to NAD, during reduction to NADH. Finally, these high-energy electrons 
from NADH are transported along an electron transport chain where, at the end, they are used to 
reduce molecular oxygen to water. 
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Figure 1. Schematic view of extraction of energy from food. 
The electron transport chain, also known as the respiratory chain, is situated in the mitochondrial inner 
membrane in eukaryotes, and in the plasma membrane in prokaryotes (Fig.2). Transfer of electrons 
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from NADH to molecular oxygen is highly favorable and a large amount of energy is released when 
electrons are transported along the respiratory chain from NADH to dioxygen. The enzymes of the 
respiratory chain conserve this energy by translocating protons across the membrane thereby 
generating an electrochemical proton gradient, DmH+, across the respective mitochondrial or bacterial 
membrane. The membrane plays a crucial role in this mechanism by forming a closed system across 
which the proton concentration gradient can be maintained. The electrochemical proton gradient is 
formed by two components: a difference in proton concentration across the membrane, plus a 
difference in electrical potential. The controlled flow of protons down the gradient can be made to do 
work, such as to drive ATP synthesis. This is called the chemiosmotic theory, a mechanism for the 
coupling of electron transfer through a series of carriers to ATP synthesis, first proposed by Peter 
Mitchell (1961).  
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Figure 2. A simplified view of the mitochondrial respiratory chain. Movement of electrons (white 
arrows) and protons (black arrows) are indicated. 
Cytochrome c oxidase is the terminal enzyme in the respiratory chain of mitochondria and many 
aerobic bacteria. It catalyzes the reduction of molecular oxygen to water and this redox reaction is 
coupled to proton translocation across the membrane.  
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2. Review of the literature 
2.1 The components of an aerobic respiratory chain  
2.1.1 The mitochondrial respiratory chain 
The mitochondrial respiratory  chain (Fig. 2, 3A) is composed of energy-transducing, multi-subunit 
enzyme complexes, designated complex I-IV and mobile electron carriers which shuttle electrons 
between the complexes (reviewed by Saraste, 1999). The first enzyme in this chain is complex I 
(NADH:ubiquinone oxidoreductase) which transfers electrons from NADH to ubiquinone (UQ) and 
couples this redox reaction to translocation of protons across the membrane (reviewed by Brandt, 
1997; Guénebaut et al., 1998). Complex I is by far the largest enzyme of the respiratory chain. The 
mammalian enzyme consists of at least 42 different subunits. This enzyme contains one noncovalently 
bound flavin mononucleotide (FMN) and several iron-sulfur centers (Fe-S) as prosthetic groups. The 
oxidation of NADH by complex I is linked to translocation of two protons per electron, but the exact 
mechanism is not yet known (Wikström, 1984; Brandt, 1997).  
Complex II (succinate:ubiquinone reductase) (Fig. 2) is also a component of the citric acid cycle. It 
catalyzes the electron transfer from succinate to ubiquinone, and contains one flavin adenine 
dinucleotide (FAD), several iron-sulfur centers and a protoheme as prosthetic groups. The enzyme is 
anchored into the membrane but does not contribute directly to the formation of DmH+. 
Complex III (ubiquinol:cytochrome c oxidoreductase) is also commonly referred to the cytochrome 
bc1 complex. The cytochrome bc1 complex from bovine heart mitochondria is a dimer with one 
monomer containing 11 subunits, three of which have active redox centers (Zhang et al., 1998; Iwata 
et al., 1998). The redox centers; two protohemes, heme C and an iron-sulfur center, are located in 
the so-called cytochrome b, the cytochrome c1 and the Rieske-type iron-sulfur protein subunits, 
respectively. The cytochrome bc1 complex translocates net one proton across the membrane per 
electron transported to cytochrome c. The mechanism by which this enzyme couples electron transfer 
to proton translocation is called the protonmotive Q cycle (Mitchell, 1976; Trumpower, 1990). 
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Figure 3. The aerobic respiratory chains. A, in mitochondria, B, in E. coli and C, in P. denitrificans. 
Enzymes which pump protons are enclosed in white boxes. UQH2, ubiquinol; Cyt c, cytochrome c. 
Complex IV, cytochrome c oxidase, is the last enzyme of the mitochondrial respiratory chain. This 
cytochrome aa3 type of oxidase catalyzes the reduction of dioxygen to water. Furthermore, it couples 
this redox reaction to the translocation of one proton across the mitochondrial membrane per each 
electron transported to dioxygen (reviewed by Babcock and Wikström, 1992; Ferguson-Miller and 
Babcock, 1996). The enzyme has 13 subunits, two of which have redox-active metal centers. Of 
these redox centers three (two A type hemes and a copper ion) are located in subunit I and one (a 
dinuclear copper center) resides in subunit II. 
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In the mitochondrial (and bacterial) respiratory chain there are two mobile electron carriers, viz. 
ubiquinone and cytochrome c. Ubiquinone is a small, hydrophobic, two electron and two proton 
carrier present in the lipid bilayer. Due to its small size and hydrophobicity, it is freely diffusible within 
the lipid bilayer and can shuttle reducing equivalents between the less mobile enzyme complexes. It is 
composed of a benzoquinone ring, which is directly involved in the redox reactions, and a highly 
hydrophobic isoprenoid tail, which accounts for its hydrophobic nature. The number of isoprene units 
present in the native ubiquinone molecule varies with species. The ubiquinone molecule can accept or 
donate either one or two electrons. When a proton and an electron are transferred to the fully 
oxidized ubiquinone (UQ), the neutral half-reduced semiquinone (UQH·) is formed. The fully reduced 
ubiquinol (UQH2) carries two electrons and two protons. Ubiquinol is able to act between two-
electron donor and one-electron acceptor systems. Cytochrome c is a small, soluble protein with a 
covalently attached heme C. It is a one-electron carrier that is found in the mitochondrial 
intermembrane space (and periplasm of bacteria), and transfers electrons between the cytochrome 
bc1 complex and cytochrome c oxidase. 
2.1.2 The aerobic respiratory chain of Escherichia coli 
In contrast to the mitochondria, bacteria are more versatile ie. in their modes of energy production. 
They usually have branched respiratory pathways and often express several terminal oxidases 
(García-Horsman et al., 1994a). These alternative respiratory routes enable bacteria to adapt to a 
variety of growth conditions and other alterations in the environment. However, in the presence of 
oxygen, aerobic respiration is the most efficient way to conserve energy (Unden and Bongaerts, 
1997). 
The aerobic respiratory system of E. coli (Fig. 3B) contains a variety of flavoprotein dehydrogenases, 
able to oxidise different substrates, such as succinate, lactate and fumarate. The flavoprotein 
dehydrogenases donate electrons to ubiquinone or menaquinone present in the membrane (reviewed 
by Gennis and Stewart, 1996).  
In the respiratory chain of E. coli there is a homologue of the mitochondrial complex I, designated 
NDH-I (Gennis and Stewart, 1996; Guénebaut et al., 1998). E. coli also contains another NADH 
dehydrogenase, NDH-II (Gennis and Stewart, 1996), which has a much simpler structure and which 
transfers electrons from NADH to ubiquinone without translocating protons. There is no cytochrome 
c-dependent branch in the respiratory chain of E. coli, however, E. coli contains two terminal quinol 
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oxidases, termed cytochromes bo3 and bd, the expression of which is regulated by the oxygen 
concentration (Gennis and Stewart, 1996). 
Cytochrome bo3 is structurally and functionally homologous to the mitochondrial cytochrome c 
oxidase despite containing one less redox metal center than cytochrome c oxidase as it lacks the CuA 
site in subunit II. This enzyme has two heme irons and a copper ion as prosthetic groups, and it 
accepts electrons from ubiquinol. The enzyme is composed of four subunits. Cytochrome bo3 
predominates when E. coli is growing at high oxygen concentration. In addition to catalyzing the 
separation of protons and electrons during quinol oxidation, it also translocates protons across the 
membrane (Puustinen et al., 1989; 1991).  
Most of the terminal oxidases are structurally and functionally related to each other and they form a 
family of heme-copper oxidases (Calhoun et al., 1994; García-Horsman et al., 1994a; chapter 2.2.1). 
Cytochrome bd is a two-subunit enzyme, which shares no sequence homology with the enzymes of 
this family and contains no copper and therefore does not belong to the family of heme-copper 
oxidases (Anraku and Gennis, 1987; Osborne and Gennis, 1999). Cytochrome bd contains two 
protohemes and heme D as prosthetic groups. Cytochrome bd has been shown to have about 100 
times higher affinity for oxygen than cytochrome bo3. Its expression is induced when the oxygen 
tension of the growth medium is low (reviewed by Jünemann, 1997). Cytochrome bd does not 
translocate protons, nevertheless, the net result of the reaction catalysed by cytochrome bd is an 
electrogenic transfer of one proton per electron across the membrane resulting from quinol oxidation 
(Puustinen et al., 1991). It has been suggested that depending on the energy requirements of the cell, 
E. coli can switch between the expression of these two oxidases (Puustinen et al., 1991). 
Cytochrome bd may also play a role in the transition between aerobic and anaerobic growth of the E. 
coli at low oxygen concentrations (Jünemann, 1997; Osborne and Gennis, 1999). 
 2.1.3 The aerobic respiratory chain of Paracoccus denitrificans 
The aerobic respiratory chain of P. denitrificans (Fig. 3C) consists of homologues of the 
mitochondrial complex I, complex II and the cytochrome bc1 complex. In addition, there are three 
terminal oxidases which all belong to the family of heme-copper oxidases, and allow P. denitrificans 
to grow under different oxygen concentrations (De Gier et al., 1994). 
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One of the three terminal oxidases in P. denitrificans, cytochrome aa3, is a close structural and 
functional homologue of the mitochondrial cytochrome aa3-type of cytochrome c oxidase, and the 
respiratory pathway leading to this enzyme closely resembles that found in the mitochondria (Fig. 3C). 
Cytochrome aa3 is comprised of four subunits which contain two A type hemes and two copper 
centers as prosthetic groups. As with the mitochondrial enzyme it translocates one proton across the 
bacterial membrane per electron transferred to dioxygen (Solioz et al., 1982; De Gier et al., 1994). 
Another terminal oxidase of P. denitrificans is cytochrome ba3, which is a four-subunit proton 
translocating quinol oxidase (Richter et al., 1994; Puustinen et al., 1989; Pfitzner et al. 1998). The 
electron transport chain which leads to cytochrome ba3 branches at the level of ubiquinol (Fig. 3C). 
Biochemical and spectroscopic studies have shown that cytochrome ba3 contains one copper ion, a 
protoheme and a heme A as prosthetic groups (Ricter et al., 1994). However, there have been 
conflicting reports on the heme composition of this enzyme. De Gier et al. (1994) has suggested that 
this enzyme has two protohemes.  
The third terminal oxidase of P. denitrificans is a cbb3-type cytochrome c oxidase which has three 
subunits (De Gier et al., 1996; Toledo-Cuevas et al., 1998). It has three c-type cytochromes, two 
protohemes and one copper ion as redox active prosthetic groups. This enzyme translocates protons 
(Raitio and Wikström, 1994) and it is expression is induced under microaerophilic conditions (De 
Gier et al., 1996).  
2.2 The general structure of the heme-copper oxidases 
2.2.1 Family of the heme-copper oxidases 
Common features for all heme-copper oxidases are six highly-conserved histidine residues in subunit I 
which ligate the redox active metal centers and the unique binuclear heme iron-copper dioxygen 
reduction site. Two main subgroups can be identified within this family of heme-copper oxidases, 
differing at the immediate electron donor. The cytochrome c oxidases accept electrons from 
cytochrome c, with the best studied representative of this group being the cytochrome aa3 from 
bovine heart mitochondria. The second subgroup is formed by the quinol oxidases for which 
membrane soluble quinols are the immediate electron donors. This class is often represented by 
cytochrome bo3 from E. coli.  
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Heme-copper oxidases generally have a common three subunit core which corresponds to the three 
mitochondrially encoded subunits of the eukaryotic cytochrome c oxidase (García-Horsman et al., 
1994a) (Fig 4). Bacterial heme-copper oxidases usually have only one additional subunit. Eukaryotic 
heme-copper oxidases have a more complicated structure. For example, cytochrome aa3 from 
bovine heart mitochondria has 10 subunits in addition to the three subunit core. Despite their simpler 
structure, the bacterial enzymes function similarly to the mitochondrial enzyme. To date, site-specific 
mutagenesis of bacterial oxidases combined with a variety of spectroscopic methods has provided a 
wealth information about the structure and function of these enzymes (Hosler et al., 1993). The 
elucidation of the crystal structures of cytochrome c oxidases from both bovine heart mitochondria 
and P. denitrificans improved the structural understanding of these enzymes and provided a better 
basis for functional studies (Iwata et al., 1995; Tsukihara et al., 1995; Tsukihara et al., 1996). At 
present for E. coli cytochrome bo3, the highest resolution structure is only to 6 Å (Gohlke et al., 
1997). 
 
 
 
 
 
 
 
Figure 4. The three core subunits of cytochrome c oxidase from P. denitrificans: the subunit I 
(coloured ribbons; amino-terminus is blue and carboxy -terminus is red), II (light gray cylinders) and 
III (dark gray cylinders) a) Viewed parallel to the membrane b) A view of the transmembrane helices 
of subunits I, II and III along the membrane normal from the outside, which indicates the 
intermembrane space in mitochondria and periplasmic space in bacteria. Also heme a and heme a3 
(black) are visible in the figures. The figures were produced using the program MolScript (Kraulis 
1991). 
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Figure 4a 
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Figure 4b 
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2.2.2 The structure and the prosthetic groups of subunit I 
Subunit I is best conserved among the heme-copper oxidases (Chepuri et al., 1990; Keightley et al., 
1995). There are 12 transmembrane a-helical segments in subunit I of cytochrome aa3 from P. 
denitrificans and bovine heart mitochondria (Iwata et al., 1995; Tsukihara et al., 1996), which form 
three semi-circles consisting of four helices each (Fig. 5). Three pores, designated, A, B and C are 
formed in the center of these semi-circles  (Iwata et al., 1995; Tsukihara et al., 1996). Cytochrome 
bo3 from E. coli has 15 transmembrane helices. There is one additional transmembrane helix at the 
amino terminus and two additional transmembrane helices at the carboxy terminus (Chepuri et al., 
1990; Gohlke et al., 1997). Subunit III of cytochrome bo3 from E. coli has two transmembrane 
helices less when numbering from the amino terminus compared to cytochrome aa3 from P. 
denitrificans and bovine heart mitochondria. The genes encoding subunit I and III are situated next to 
each other in the cyo operon encoding cytochrome bo3 and therefore, a genetic transfer has most 
likely occurred between the two genes (Chepuri et al., 1990). 
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Figure 5. Structure of subunit I of cytochrome aa3 from P. denitrificans showing the redox active metal 
centers; heme a and a3 (red) and CuB (blue), transmembrane helix (green cylinders) arrangement and the 
pores A, B and C formed in the center of these helices. The figure was produced using program Insight II 
(Version 97.0 Molecular Modeling System, Molecular Modeling Simulations Inc., 1997). 
 
Three types of hemes are found in subunits I of the heme-copper oxidases: protoheme (heme B), 
heme O and heme A. Protoheme has a vinyl group at position 2 and a methyl group at position 8 and 
its optical spectrum has an a-peak at 556 nm. Heme O differs from protoheme by having a 
hydroxyethylfarnesyl group at position 2, and the a-peak at 553 nm. Heme A also has a 
hydroxyethylfarnesyl group at position 2 and in addition a formyl group at position 8. Its optical 
spectrum has the a-peak at 587 nm (Caughey et al., 1975; Puustinen and Wikström, 1991; Wu et 
al., 1992). 
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The low-spin heme group (heme a) of cytochrome aa3 from P. denitrificans and from bovine heart 
mitochondria is a heme A moiety (Iwata et al., 1995; Tsukihara et al., 1996). The axial ligands of the 
iron, Fea, are His94 (His61) and His413 (His378) from transmembrane helices II and X, respectively 
(Lemieux et al., 1992; Shapleigh et al., 1992; Iwata et al., 1995; Tsukihara et al., 1996). In the E. 
coli cytochrome bo3 this heme group (heme b) is predominantly a protoheme and contains the iron 
designated Feb. However, in strains of E. coli where genes of cytochrome bo3 have been 
overexpressed, heme O can also be found at this site. The resulting oo3-type oxidase is fully functional 
(Puustinen et al., 1992). The low-spin heme is situated within pore C (Fig. 5), with its propionate 
groups pointing towards the intermembrane space in mitochondria and periplasm in bacteria. The 
hydroxyethylfarnesyl group points towards the matrix in mitochondria and cytosol in bacteria. The 
heme plane is perpendicular to the membrane and the iron is located at a depth of about 1/3 of the 
membrane thickness from the outside (Iwata et al., 1995; Tsukihara et al., 1996).  
The high-spin heme (heme a3) is also a heme A moiety in cytochrome aa3 from P. denitrificans and 
from bovine heart mitochondria. Histidine 411 (His376) in transmembrane helix X ligates the iron, 
Fea3 (Calhoun et al., 1993; Iwata et al., 1995; Tsukihara et al., 1996). In E. coli cytochrome bo3 the 
heme in the binuclear center is heme O (Puustinen and Wikström, 1991). Deletion of a gene, cyo E, a 
member of the heme O biosynthetic pathway blocked the formation of heme O plus caused 
incorporation of protoheme into the binuclear site. The resulting bb3-type oxidase produced was non-
functional (Saiki et al., 1992; Nakamura et al., 1997). This is an interesting observation since a 
protoheme is found at that site in the cbb3-type of oxidases (García-Horsman et al., 1994b; De Gier 
et al., 1996). The high-spin heme is located in pore B (Fig. 5) and its propionate groups are pointing 
towards the intermembrane space in mitochondria and periplasmic space in bacteria. The 
hydroxyethylfarnesyl side chain penetrates into the lipid bilayer (Iwata et al., 1995; Tsukihara et al., 
1996). The high-spin heme forms the binuclear, oxygen-reducing site together with a copper ion, CuB.  
The copper atom known as CuB is located about 5 Å from the high-spin heme iron. EXAFS and 
ENDOR spectroscopy of cytochrome aa3-600 from Bacillus subtilis has shown that the fully 
oxidized enzyme has a tetragonal CuB site with three histidine ligands and one oxygen ligand with an 
exchangeable proton(s) (Fann et al., 1995). The three histidine ligands of CuB are His325 (His290) 
and His326 (His291) from helix VII and His276 (His240) from helix VI (Hosler et al., 1993; Iwata et 
al., 1995; Tsukihara et al., 1996). The histidine residues 276 (His240) and 326 (His291) but not 
histidine 325  (His290) were seen as CuB ligands in the crystal structure of the four subunit, fully 
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oxidized and azide-bound cytochrome aa3 from P. denitrificans (Iwata et al., 1995). All three 
histidines are seen as ligands of CuB in the different redox and ligand-bound forms of the bovine 
enzyme (Tsukihara et al., 1996; Yoshikawa et al., 1998). In the more recent crystal structure of the 
oxidized two-subunit Paracoccus enzyme all three histidine ligands of CuB are visible (Ostermeier et 
al., 1997). EXAFS data for cytochrome bo3 indicates that reduction of the binuclear site weakens the 
bond between CuB and one of the histidine ligands and that binding of CO causes a loss of one of the 
histidine ligands (Ralle et al., 1999) 
A covalent bond between the His276 (His240) and the Tyr280 (Tyr244) was suggested based on the 
two cytochrome c oxidase crystal structures (Yoshikawa et al., 1998; Ostermeier et al., 1997). This 
covalent bond was confirmed by a protein chemical analysis of four different cytochrome c oxidases 
(Buse et al., 1999), but the importance of this post-translational modification is not yet known. It has 
been postulated that this histidine-tyrosine covalent bond may alter the chemical properties of the 
tyrosine in such a way that it can participate in the catalytic cycle as donor of a proton and an 
electron, thereby forming a tyrosine radical (Das et al., 1998; Proshlyakov et al., 1998; MacMillan et 
al., 1999). 
Additionally, a non-redox-active Mg2+or Mn2+ bound to subunit I of the cytochrome c oxidases has 
been identified (Haltia, 1992; Hosler et al., 1995; Espe et al., 1995). This metal site is located above 
the binuclear site, at the edge of subunit I, very close to subunit II (Hosler et al., 1995; Ostermeier et 
al., 1997; Yoshikawa et al., 1998). The bound metal is ligated by Glu218 (Glu198) from subunit II, in 
addition to amino acid residues and water molecules from subunit I (Ostermeier et al., 1997; 
Yoshikawa et al., 1998). The importance of this metal site is not known. It has been suggested to 
have a structural role and/or it may coordinate the interaction of subunits I and II (Hosler et al., 1995; 
Mills and Ferguson-Miller, 1998). The functional role of the bound metal has been tested by site-
specific mutagenesis of the metal ligating residues (Fetter et al., 1995; Hosler et al., 1995). In resulting 
mutant enzymes, where the metal site was empty, proton translocation was unaffected and the 
catalytic activity was only slightly inhibited. This site is not present in the quinol oxidases (Hosler et al., 
1995). Therefore, a possible regulatory role for this metal ion in the electron transfer from CuA (see 
chapter 2.2.3) to heme a could be conceivable. 
Another non-redox-active metal site is located in subunit I of cytochrome aa3 from P. denitrificans 
and bovine heart mitochondria (Ostermeier et al., 1997; Yoshikawa et al., 1998). This site is located 
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at the top of the first transmembrane helix, close to the periplasmic  membrane surface in the 
bacterium and the intermembrane surface in mitochondria. The identity of the bound metal can not be 
firmly determined from the present crystal structures. However, it was suggested based on the 
analysis of the metal coordination profile that a Ca2+ is bound at this site in the Paracoccus enzyme 
(Ostermeier et al., 1997). In the bovine enzyme this site is proposed to be occupied by a Na+ 
(Yoshikawa et al., 1998). The role of this site is also not known (see chapter 5.3). 
2.2.3 The structure and the metal center of subunit II 
Subunit II has two transmembrane helices and a large hydrophilic domain at the carboxy terminus 
formed by a ten-stranded b-sheet structure (Chepuri and Gennis 1990; Iwata et al., 1995; Tsukihara 
et al., 1996). The amino terminus of E. coli cytochrome bo3 subunit II contains a signal sequence 
which is proteolytically cleaved, and lipid molecules are covalently attached to the new amino terminus 
(Ma et al., 1997). 
Subunit II of cytochrome c oxidases contains a copper center, CuA. The CuA binding site was 
originally assigned as a mononuclear copper site but later found to be a mixed-valence binuclear site 
(Kroneck et al., 1990; Lappalainen et al., 1993; Malmström and Aasa, 1993). The residues, which 
ligate CuA center are His181 (His161), His224 (His204), Cys216 (Cys196), Cys220 (Cys200) and 
Met227 (Met207), which were assigned by Kelly et al. (1993). In addition to these five ligands, a 
peptide carbonyl of Glu218 (Glu198) was identified as a sixth ligand by Iwata et al., (1995) and 
Tsukihara et al., (1995).  
This copper site is not present in subunit II of the quinol oxidases. The CuA site has been restored in 
cytochrome bo3 of E. coli by the introduction of the metal ligating amino acid residues (Van der Oost 
et al., 1992). The ability to reconstruct the CuA site in cytochrome bo3 suggests that the overall 
structure of subunit II is similar in quinol oxidases and cytochrome c oxidases but that in quinol 
oxidases the copper ligating residues are no longer conserved (Van der Oost et al., 1992; Wilmanns 
et al., 1995). This observation has been confirmed by a crystal structure of the periplasmic fragment 
of subunit II from cytochrome bo3 (Wilmanns et al., 1995).  
Cytochrome c is the direct electron donor to cytochrome c oxidase and the cytochrome c binding 
domain is present on subunit II (Bisson et al., 1982; Millet et al., 1983). Several well conserved 
carboxylic acid residues in subunit II of cytochrome c oxidases have been proposed to interact 
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electrostatically with the lysine residues of cytochrome c (Lappalainen et al., 1995; Witt et al., 1995; 
1998a; 1998b). All of these conserved carboxylic acids, presumably involved in cytochrome c 
binding, are absent from subunit II of quinol oxidases (Chepuri et al., 1990).  
The quinol binding site in the quinol oxidases has been mapped to subunit II by chemical 
photolabelling, quinol analogues and site-specific mutagenesis studies (Welter et al., 1994; Sato-
Watanabe et al., 1994a; 1998; Tsatsos et al., 1998; Ma et al., 1998). Tryptophan 136 (Trp104) in 
subunit II has been proposed to be situated at or close to the quinol binding site in cytochrome bo3 of 
E. coli (Ma et al., 1998). The possibility also exists for there to be two quinol binding sites in 
cytochrome bo3. One of these sites would be a “high-affinity” ubiquinol binding site (QH) (Sato-
Watanabe et al., 1994a) and the other one a “low-affinity” ubiquinol binding site (QL) (Sato-
Watanabe et al. 1994b). The proposed QH site would mediate electron transfer from the QL site, 
which is assigned as the substrate oxidation site, to the low-spin heme (Sato-Watanabe et al., 1994a). 
2.2.4 Subunit III 
Subunit III of cytochrome aa3 from P. denitrificans and bovine heart mitochondria contains seven 
transmembrane helices arranged into two bundles. One bundle is formed by the first two helices and 
the other by the last five helices (Iwata et al., 1995; Tsukihara et al., 1996). These two bundles are 
separated by a large V-shaped cleft, which contains lipid molecules; one tightly bound phosphatidyl 
choline in the Paracoccus enzyme and two phosphatidyl ethanolamines and one phosphatidyl glyserol 
in the bovine enzyme. Subunit III of E. coli cytochrome bo3 has five transmembrane helices (Chepuri 
et al., 1990; Gohlke et al., 1997; see chapter 2.2.2).  
Subunit III does not contain any prosthetic groups and its importance for the enzyme is largely 
unknown, as the two subunit enzyme from P. denitrificans has been shown to be fully active and able 
to translocate protons (Solioz et al., 1982). However, based on gene deletion studies it was proposed 
that subunit III is needed for the correct assembly of the enzyme and it may also stabilize the mature 
oxidase (Haltia et al., 1989; 1991; 1994; Echabe et al., 1995).  
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2.2.5 Other subunits 
Cytochrome bo3 from E. coli and cytochrome aa3 from P. denitrificans both have a fourth subunit. 
Subunit IV of the Paracoccus enzyme has one transmembrane helix and is not homologous to any 
previously known protein (Iwata et al., 1995; Witt and Ludwig, 1997). Subunit IV of the E. coli 
enzyme has three transmembrane helices (Chepuri et al., 1990; Gohlke et al., 1997). The role of 
subunit IV is not known but in E. coli it has been proposed to assist the enzyme assembly (Saiki et 
al., 1997). 
In addition to the three mitochondrially-encoded subunits, cytochrome aa3 from bovine heart 
mitochondria has ten nuclear-encoded subunits of which subunit Vb on the matrix side has a Zn2+ 
binding site (Tsukihara et al., 1995; 1996). The importance of these nuclear-encoded subunits for the 
eukaryotic oxidases is not known but it has been suggested that they have regulatory functions 
(Kadenbach et al., 1991; Frank and Kadenbach, 1996).  
2.3 The catalytic cycle of cytochrome c oxidase and the 
conservation of energy 
2.3.1 Mechanism for energy transduction in cytochrome c oxidase 
The overall reaction catalyzed by cytochrome c oxidase may be written as,  
4e -out + 8H+in + O2 ® 2H2O + 4H+out 
Where "in" indicates the matrix space in mitochondria and the cytosol in bacteria, and "out" indicates 
the intermembrane space in mitochondria and periplasmic space in bacteria (Fig. 2).  
The energy released during the catalytic cycle of the enzyme is transduced to an electrochemical 
proton gradient across the membrane by two means. First, the chemical reaction directly generates 
electrical potential as electrons and protons for dioxygen reduction are obtained from the opposite 
sides of the membrane (Fig. 6). Secondly, the enzyme is a proton pump which translocates one 
proton across the membrane per each electron transported to dioxygen (Fig. 6) (Wikström, 1977). 
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Figure 6. Scheme of cytochrome c oxidase in the membrane showing the redox active metal centers 
(modified from Verkhovsky et al., 1999). Proton and electron movement is indicated by the arrows. 
The substrate dioxygen and the product water are also shown.  
The catalytic cycle of cytochrome c oxidase is divided into two phases. The first is a reductive or 
"electron-filling" phase and the second is the oxidative phase when the electrons are used to reduce 
dioxygen (Fig. 7) (reviewed by Babcock and Wikström, 1992 and Ferguson-Miller and Babcock, 
1996). The reduction of dioxygen begins when the two-electron reduced binuclear site binds 
dioxygen. Dioxygen enters the binuclear site by first binding transiently to CuB and after that to Fea3 
(Woodruff, 1993; Lemon et al., 1993). The initial ferrous heme-oxy intermediate A was first 
observed by Chance et al. (1975) using low temperature kinetic methods. The initial binding of 
dioxygen to Fea3 is weak (Chance et al., 1975; Verkhovsky at al., 1996a). However, in the next 
redox step dioxygen is trapped kinetically by an extremely fast electron transfer from Fea to dioxygen 
bound Fea3 (Verkhovsky et al., 1994; 1996b). The resulting intermediate, compound P, was initially 
proposed to be a ferric peroxy O–O form of the binuclear center (Hill and Greenwood, 1984; 
Verkhovsky et al., 1994; Morgan et al., 1996). However, recent resonance Raman spectroscopic 
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studies (Proshlyakov et al., 1997; 1998) and mass spectrometric work (Fabian et al., 1999) have 
shown that the O–O bond is already broken in this intermediate. 
In the next step the oxy-ferryl intermediate F is formed (Varotsis and Babcock, 1990; Han et al., 
1990; Ogura et al., 1993; Morgan et al., 1996). Finally, the fourth electron moves to the binuclear site 
and the fully oxidized enzyme O is generated (Hill, 1991; Babcock and Wikström, 1992). The 
dioxygen reaction intermediates described above have also been detected in cytochrome bo3 from E. 
coli, which suggests that the oxygen reaction is similar in the cytochrome c and quinol oxidases 
(Verkhovsky et al., 1996a; Morgan et al., 1995; Puustinen et al., 1996). 
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Figure 7. Model for the catalytic cycle of cytochrome c oxidase, as modified from Wikström (1998). 
The four protons and four electrons consumed in the reduction of dioxygen to water are shown as 
well as protons translocated during P ® F and F ® O transitions. R, reduced; A, heme-oxy; P, 
peroxy; F, ferryl; O, oxidized and E, one electron reduced reaction intermediate. 
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2.3.2 Proton transfer during dioxygen reduction 
A total of four protons are needed to complete the reduction of dioxygen to two water molecules. 
The enzyme takes up two protons during the two-electron reduction of the binuclear site. Neither the 
binding of oxygen to the enzyme nor the A ® P conversion is associated with net uptake of protons 
(Oliveberg et al., 1991). Two protons are taken up during the oxidative phase of the catalytic cycle 
connected to the P ® F and F ® O conversions. Wikström (1989) showed that proton translocation 
by the enzyme is energetically coupled to the P ® F and F ® O transitions. These two steps were 
suggested to be coupled to translocation of two protons each (Wikström, 1987,1989). Thus, the four 
electron transfer steps needed to complete the reduction of dioxygen to water are not equal with 
respect to coupling to proton translocation. 
Time-resolved measurement of the generation of an electrical membrane potential combined with 
parallel optical detection has shown that in the fully reduced enzyme the main charge translocation 
events occurs during the P ® F and F ® O transitions (Verkhovsky et al., 1997; Jasaitis et al., 
1999). Recently Verkhovsky et al. (1999) measured the timing of the proton translocation events by a 
direct determination of proton translocation during partial turnover. The authors observed that 
translocation of four protons occurs only if re-reduction of the enzyme immediately follows the 
oxidative phase of the catalytic cycle. A new intermediate, O~, was postulated to explain these 
results. It is a high energy intermediate and an immediate product of the oxidative phase of the 
catalytic cycle, which dissipates into intermediate O if electrons are not supplied at a sufficient rate to 
re-reduce the enzyme.  
Both a direct and an indirect coupling mechanism have been proposed for redox-linked proton 
translocation in cytochrome c oxidase (Krab and Wikström, 1987; Morgan et al., 1994). In the direct 
coupling system one of the redox-active prosthetic groups is directly involved in proton pumping. In 
the indirect coupling mechanism, the energy from the redox chemistry is transmitted by conformational 
changes of the protein structure allowing the pump element to be located at some distance from the 
redox center.  
Rich et al. (1998) proposed a general model for direct energy coupling in the heme-copper oxidases, 
which they called the “glutamate trap”. This model is based on the principle of electroneutrality, where 
all electron transfers to the binuclear site are made electroneutral by protonation changes (Rich 1995). 
When electrons are transported to the binuclear site protons are taken up into the "trap" from the 
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proton-input side of the membrane to maintain electroneutrality. The chemical transformation of 
dioxygen and subsequent uptake of protons for water formation provides a driving force in the form 
of electrostatic repulsion, to eject protons from the "trap".  
In the original “histidine cycle” model, one of the histidine ligands of CuB functions as a two proton 
carrier. This histidine alternates between the imidazolium (ImH2+) form, which is not ligated to CuB 
and which is stabilized by a negative charge at the oxygenous ligand, and the imidazolate (Im-) form, 
which is ligated to CuB (Wikström et al., 1994; Morgan et al., 1994). The original “histidine cycle” 
model explained how two protons can be transported simultaneously (Wikström et al., 1994; 1998; 
Morgan et al., 1994). This model also fulfilled some important requirements of coupling redox 
chemistry to proton translocation in cytochrome c oxidases. The enzyme pumps protons against a 
proton concentration gradient and therefore, a gating function is needed for the pump element to 
control input and output conformations and to prevent proton backflow. To prevent short-circuiting 
the mechanism it is physically and temporarily obligatory to separate translocated protons from 
protons involved in the dioxygen chemistry. Electron entry to the binuclear site must also be gated so 
that the protonation of the pump element can occur before the redox chemistry is completed. Later, a 
similar model was proposed by Iwata et al. (1995).  
Michel (1998) proposed a model based on the crystallographic data and a re-evaluation of published 
results as to how the process of proton translocation might work. This proposal challenged the 
generally accepted pumping model as it suggested that the F ® O transition is coupled to the 
pumping of only one proton and translocation of one proton is mechanistically and energetically 
coupled to the reductive phase of the catalytic cycle. Experimental observations are, however, 
inconsistent with this model (Jasaitis et al., 1999; Verkhovsky et al., 1999). Additionally, the key 
point of how the gating of protons is accomplished is not fully addressed. Recently, Wikström (2000) 
presented a proton translocation mechanism, a new “histidine cycle” model, that is consistent with the 
earlier data from titration of the oxidase reaction intermediates with phosphorylation potential in 
isolated mitochondria (Wikström, 1989) and new experimental findings (Jasaitis et al., 1999; 
Verkhovsky et al., 1999). As proposed in the original “histidine cycle” model, a histidine residue, 
His326 (His291), which is a ligand of CuB is intimately involved in proton translocation. 
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2.4 The proton conducting pathways in cytochrome c oxidase 
2.4.1 Molecular mechanism for proton transfer  
The fundamental structural element for proton transport inside proteins is a continuous chain of 
hydrogen bonds, termed a "proton wire", which can be formed by water molecules and amino acid 
side chains. The transportation of protons along such "wires" takes place very rapidly over long 
distances via a two-step mechanism (Nagle and Morowitz, 1978; Nagle et al., 1980). In the first step 
the proton is transported by sequential hopping of successive protons through hydrogen bonds until 
the end of the chain is reached and a proton is released. In a second step, the chain of hydrogen 
bonds between the water molecules and amino acid side chains reorients to return the protonic 
configuration to its original state to allow the transport of another proton (Nagle and Morowitz, 
1978).  
In the narrow transmembrane gramicidin A channel protons are transported along a single-file 
hydrogen-bonded chain of water molecules (Pomès and Roux, 1996; Pomès and Roux, 1998). 
Chains of water molecules have also been proposed to play important roles in protonation reactions in 
the photosynthetic reaction center from R. sphaeroides (Baciou and Michel, 1995), the cytochrome 
b6f complex (Martinez et al., 1996; Ponamarev and Cramer, 1998) and bacteriorhodopsin (Pebay-
Peyroula et al., 1997; Lanyi, 1997). Bacteriorhodopsin, a light-driven proton pump, is the best 
understood proton translocating membrane protein to date (reviewed by Heberle, 2000). Aspartic 
acid 96 in the proton uptake pathway of bacteriorhodopsin is the internal proton donor to the retinal 
Schiff base in the center of the membrane. However, this aspartic acid is located about 11 Å away in 
a hydrophobic cavity and therefore water molecules have been suggested to provide the proton 
transfer route between the two. The proton exit pathway of this enzyme involves both amino acid side 
chains and at least three tightly bound water molecules which have been detected by X-ray 
crystallography. 
The binuclear site in cytochrome c oxidase, the site where protons are needed for the catalytic 
reaction, is buried deep within the protein interior. Therefore, there must be pathway(s) through the 
protein to facilitate proton access to this site. Two possible proton-conducting pathways, known as 
the D-channel and the K-channel, have been described in subunit I (Fig. 8) (see Wikström, 1998). In 
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addition, an exit pathway for translocated protons has also been suggested (Puustinen and Wikström, 
1999). 
 
Figure 8.  Subunit I of cytochrome c oxidase showing the structures of the proposed D- and K-
channels for proton entry and the possible exit pathway (Wikström 1998). Water molecules predicted 
in paper III are shown as single circles. The important amino acid residues are indicated (numbering 
of amino acids refers to cytochrome aa3 of bovine heart mitochondria). 
2.4.2 The D-channel and Glu278 (242) in cytochrome c oxidase 
The D-channel (Fig. 8) conducts both the protons to be translocated and the protons needed for 
dioxygen chemistry during the oxidative phase of the reaction cycle (Svensson-Ek et al., 1996; 
Ädelroth et al., 1997; Puustinen et al., 1997). It is also possible that the D-channel participates in 
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proton uptake during the reductive phase of the catalytic cycle (Wikström et al., 1998). The D-
channel is comprised of amino acid residues, Asp 124 (Asp91), to Ser193 (157) after which there is 
a hydrophobic cavity according to the crystal structures. A clear protonic connectivity from Ser193 
(157) to the binuclear site was not structurally identified (Iwata et al., 1995). 
The highly conserved Asp124 (Asp91) is located at the entrance of the D-channel in subunit I, 
between transmembrane helices II and III at the proton input side of the membrane (Fig. 8). 
Substitution of this residue with an asparagine in cytochrome bo3 from E. coli, R. sphaeroides and P. 
denitrificans abolishes proton translocation (Thomas et al., 1993a; Fetter et al., 1995; Pfitzner et al., 
1998).  
From Asp124 (Asp91) the D-channel continues to Asn113 (Asn80) and Asn131 (Asn98). 
Nonconservative mutations of Asn124 (Asn80) and Asn142 (Asn98) impair proton translocation in 
cytochrome bo3 from E. coli but the mutant enzymes retain considerable electron transfer activity 
(Garcia-Horsman et al., 1995). The D-channel continues further towards the middle of membrane 
and it includes both polar amino acid residues and water molecules (Tsukihara et al., 1996; see 
chapter 5.2). Both crystal structures indicate that the D-channel ends near Ser193 (Ser157) (Iwata et 
al., 1995; Tsukihara et al., 1996).  
In the cavity where the D-channel ends, electron density for water molecule(s) is visible in the crystal 
structure of cytochrome aa3 from P. denitrificans, leading to highly a conserved glutamic acid 278 
(Glu242) (Iwata et al., 1995; Ostermeier et al., 1997). Most of the mutations of this residue result in 
an enzyme which can not complete the catalytic cycle. These results indicate that  Glu278 (Glu242) is 
an essential residue for proton translocation (Svensson-Ek et al., 1996; Ädelroth et al., 1997; 
Verkhovskaya et al., 1997). Verkhovskaya et al. (1997) substituted Glu278 (Glu242) with a cysteine 
and the resulting Glu278Cys (Glu242) mutant enzyme did not translocate protons but retained 15% of 
the wild type electron transfer activity. Based on these results, the Glu278 (Glu242) residue has been 
directly implicated in the O2 reduction and proton pumping mechanism. 
There is no obvious pathway for protons beyond Glu278 (Glu242). FTIR spectroscopy predicts the 
presence of water molecules which may connect Glu278 (Glu242) to one of the histidine ligands of 
CuB (Puustinen et al., 1997). Alternatively, Iwata et al. (1995) suggested that the proton pathway 
from Glu278 (Glu242) might continue directly to one of the propionates of heme a3.  
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2.4.3 The K-channel in cytochrome c oxidase 
The K-channel was originally proposed to transfer the substrate protons for oxygen chemistry (Hosler 
et al., 1993; Thomas et al., 1993b). However, more precise analysis of Lys354 (Lys319) mutants 
have indicated that the K-channel may be preferentially used for proton uptake only during the 
reductive phase of the catalytic cycle (Svensson et al., 1995; Hosler et al., 1996; Jünemann et al., 
1997; Konstantinov et al., 1997; Ädelroth et al., 1998). Alternatively, it has been suggested that the 
K-channel is not a proton conducting pathway at all but may function as a "dielectric well", which 
would provide transient charge compensation to charge uncompensated intermediate reaction states 
(Jüneman et al., 1997; Rich et al., 1998). Rottenberg (1998) pointed out the possibility that K-
channel could be a "hydroxyl ion wire", facilitating movement of hydroxyl anions instead of protons.  
Ser291 (Ser255) in transmembrane helix VI of subunit I at the proton input side of the membrane is 
proposed to be located at the beginning of the K-channel (Fig. 8). By electrostatic computations, 
Kannt et al. (1998a; 1998b) suggested that also the well conserved Glu78 (Glu62) in subunit II could 
function as a proton entry point for the K-channel. This prediction has been tested by a site-specific 
mutagenesis studies of cytochrome bo3 from E. coli (Ma et al., 1999). Substitution of Glu89 (Glu62) 
with an alanine or a glutamine resulted in mutant enzyme, which had lowered turnover activity (43% 
and 10% respectively when compared to the wild-type enzyme). Due to this low activity the proton 
pumping stoichiometry of these mutant enzymes could not be examined. However, results of the study 
and the proximity of Glu89 (Glu62) to Lys362 (Lys319) support the idea that Glu89 (Glu62) could 
regulate the entry or transit of protons through the K-channel (Ma et al., 1999). 
The K-channel leads towards a highly conserved Lys354 (Lys319) and further to Thr351 (Thr316), 
both located in transmembrane helix VIII  (Thomas et al., 1993b; Hosler et al., 1993). The channel 
continues up to the hydroxyl group of the hydroxyethylfarnesyl side chain of heme a3 which is near the 
hydroxyl group of Tyr280 (Tyr244). Water molecules have also been predicted to participate in 
proton conduction in the K-channel (Iwata et al., 1995; Tsukihara et al., 1996; Ostermeier et al., 
1997; Hofacker and Schulten, 1998). 
2.4.4 An exit pathway for pumped protons in cytochrome c oxidase 
The domain on the external side of the binuclear site is highly hydrophilic containing several charged 
and polar amino acid residues, the propionates of the two hemes, a Mn2+ or Mg2+ and several water 
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molecules (Fig. 8) (Iwata et al., 1995; Ostermeier et al., 1997; Tsukihara et al., 1996). The hydrogen 
bonded network they form could participate in the pathway by which translocated protons exit from 
the enzyme structure. A site-specific mutagenesis study of conserved Arg473 (Arg438) and Arg474 
(Arg439), which are hydrogen bonded to the D-propionate of heme a3, showed that this propionate 
is involved in proton translocation (Puustinen and Wikström, 1999). Based on these results, it was 
proposed that the D-propionate of heme a3 may be located at the beginning of the proton exit 
pathway. 
The hydrophilic region on the external side of the binuclear site is also connected to a structure that 
could serve as a water channel for removing H2O produced at the binuclear site (Tsukihara et al., 
1996). This possible water channel, which is lined with hydrophilic residues proceeds from the 
external side of heme a3 along the subunit I-II interface to the ouside surface of the enzyme. 
(Tsukihara et al., 1996). 
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3. Aims of the present study 
The crystal structures of cytochrome c oxidase from P. denitrificans (Iwata et al., 1995) and bovine 
heart mitochondria (Tsukihara et al., 1995; 1996) which were determined to atomic resolution are of 
key importance for making site-specific mutant enzymes to elucidate how the enzyme functions at the 
atomic level. In the present work specific mutations were made in cytochrome bo3 from E. coli and 
cytochrome aa3 from P. denitrificans. The resulting mutant enzymes were analyzed via biochemical 
and spectroscopic methods to resolve the effect of the substitution on enzymatic activity, proton 
translocation and spectroscopic properties. More specifically, the aims of the present study have 
been: 
1. To identify a route for O2 and other heme a3 ligands into the binuclear site and to analyze in detail 
the effect of the Val279Ile (Val243) mutation on ligand binding. 
2. To study the proton conduction mechanism of the D-channel. 
3. To determine whether the new metal binding site identified in the structure of subunit I is 
responsible for the Ca2+-dependent red shift in the optical spectrum of heme a. 
4. To study the interaction of the formyl group of heme a with the nearby amino acid residue.  
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4. Materials and methods 
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in 
Table1. 
Table 1. Bacterial strains and plasmids 
---------------------------------------------------------------------------------------------------------------------------------
- 
Strain  Genotype or rele vant characteristics  Parent strain and/or reference 
E. coli 
GO105  cyo,cyd,recA, KmR     GO102, Calhoun et al., 1993 
GL101  cyo,sdh,recA, KmR,TcR     GL100, Lemieux et al., 1992 
SM10  KmR, pRP4-2 (Tc::Mu)     C600, Simon et al., 1983 
SDM2  mrcA,mrcB      Vandeyar et al., 1988 
NM522         Gough and Murray, 1983 
HB101  SmR       Lacks and Greenberg, 1977 
P. denitrificans 
PD1222  RifR       De Vries et al., 1989 
PD9220  DctaDI,DctaDII      PD9218, De Gier et 
al.,1994 
AO1  GmR,DccoN,DctaDI:: KmR,DctaDII::TcR   MR31, Pfitzner et al., 1998 
----------------------------------------------------------------------------------------------------------------------- 
Plasmid  Relevant properties     Derivative of and/or reference 
E. coli 
M13SEDH SalI-EcoRI fragment from pRG110  
   with HindIII site at 3.65 kb deleted    M13mp18, Lemieux et al., 1992 
M13XE  XmaI-EcoRI fragment from pRG110   M13mp18, Lemieux et al., 1992 
pJT40  pJT39 with HindIII site at 3.65 kb restored, ApR  pL1, Lemieux et al., 1992 
pJRHisA  histidine-tag at the end of cyoA, ApR   pJT40/39, Rumbley et al., 1997 
P. denitrificans 
M13PH  PstI-HindIII fragment from pMR38   M13mp18, this work 
M13XH  XbaI-HindIII fragment from pMR49   M13mp18, this work 
pMR38  ctaDII gene, ApR     pUC19 
pMR49  ctaDII gene, SmR     pEG400 
pPDox  BamHI-HindIII fragment from pMR49,   pBBR1MCS, Pfitzner et al., 1998, 
 SmR       paper IV 
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Site-specific mutagenesis methods.  The system for in vitro mutagenesis is based on a method by 
Vandeyar et al. (1988). Site-specific mutagenesis of cytochrome bo3 from E. coli was performed as 
described originally by Lemieux et al. (1992) and Thomas et al. (1993b). The mutagenesis of 
cytochrome aa3 from P. denitrificans was as described in papers II and IV. 
All mutations were confirmed by DNA sequencing using ALFexpress DNA sequencer (Pharmacia) 
throughout all processing stages. 
Bacterial growth conditions and enzyme purification.  E. coli cells were cultured and the wild 
type and the mutant cytochrome bo3 enzymes were isolated as described by Morgan et al. (1995) 
and Puustinen et al. (1996). All cytochrome bo3 enzymes have six histidine residues (a histidine tag) 
attached to the carboxy terminus of subunit II when they are expressed from the plasmid pJRHisA 
(Rumbley et al., 1997), thus these enzymes can be purified in one step by Ni2+ affinity 
chromatography.  
The wild type and mutant strains of P. denitrificans were cultured and the enzymes purified as 
described in detail in paper IV. 
Measurement of catalytic activity and an apparent KM for O2. The O2 consumption activity and 
the apparent KM for O2 for E. coli cytochrome bo3 were measured polarographically at 25oC using a 
Clark-type oxygen electrode. The solution contained 50 mM Tris-Cl, pH 7.4, 50 mM KCl, 0.5 mM 
EDTA, 1.1 mg/ml asolectin, 0.23 mM ubiquinone-1 (UQ1) with 5.7 mM dithiothreitol present to 
keep the quinones in their reduce state. UQ1 was a gift from Hoffmann-LaRoche A.G. (Basel, 
Switzerland). The conditions of O2 consumption measurement for cytochrome aa3 from P. 
denitrificans were as described in paper IV. 
Enzyme reconstitution into proteoliposomes and proton translocation. The reconstitution 
method used in this work was originally developed by Rigaud et al. (1995), and the detailed 
description of the method for cytochrome bo3 is given by Verkhovskaya et al. (1997). 
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E. coli and P. denitrificans spheroplasts were prepared as described by Puustinen et al. (1989) and 
Verkhovskaya et al. (1992). The proton translocation was measured by the oxidant pulse method 
(Mitchell et al., 1979; Wikström and Penttilä, 1982). The reaction conditions used for Paracoccus 
spheroplasts were as described in paper IV, and those for E. coli spheroplasts as described by 
Thomas et al. (1993a), with the exception of annonin being used instead of capsaicin as the complex I 
inhibitor. Proton translocation of cytochrome bo3 reconstituted into proteoliposomes was measured in 
250 mM KCl supplemented with 1.8 mM DTT, 88 mM UQ1 and 0.9 mM valinomycin.  
Spectroscopic methods.  Optical spectra were recorded as described in papers I-V.  
FTIR spectra were recorded with a Perkin-Elmer 1760X FTIR spectrometer equipped with an ADP 
Cryogenics cryostat and a mercury cadmium telluride (MCT) detector using a method described by 
Puustinen et al. (1997) and Bruker I55 spectrometer equipped with a modified Specac cryostat and a 
Lauda RK8-CS thermostat bath circulating ethanol as described in paper II. 
The method used for room temperature flow-flash originally developed by Gibson and Greenwood 
(1963) was as described by Verkhovsky et al. (1994). The low temperature flow-flash was done 
following the method of Morgan et al. (1996) and anaerobic photolysis measurement was done as 
described by Morgan et al. (1993).  
Calculations and modelling. The apparent KM for O2 was calculated by fitting the test results to the 
hyperbolic Michaelis-Menten equation in Matlab (Mathworks, South Natick, MA). A function called 
FMINS that implements the Nelder-mead simplex algorithm was used for minimizing a nonlinear 
function of several variables. 
The most probable position of the isoleucine side chain relative to the native valine in the Val287Ile 
(Val243) cytochrome bo3 mutant enzyme (paper I) was modelled using the programme O which is a 
program for model-building in macromolecular X-ray crystallography. 
Defining the positions of helices in protein sequence alignments, the protein database search and the 
energy-minimization of enzyme structures was done as described in paper IV. 
Analysis of multiwavelength kinetic data was done as described by Morgan et al. (1995). 
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“Potentials-of-mean-force” (PMF) approach in paper III has been used to describe the existence of 
water inside protein cavities. This approach is based on a statistical mechanical expression for water-
density distribution in terms of particle correlation functions. The accuracy of the local water density 
predictions have been verified against high resolution (< 1Å) DNA and RNA crystals (Hummer et al., 
1995). 
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5. Results and discussion 
5.1 The pathway for dioxygen to the binuclear site 
A channel like structure leading from the binuclear site to the edge of subunit I was observed, in the 
electron density map of cytochrome aa3 from P. denitrificans (Fig. 9) (paper I). It is relatively wide 
and the amino acid residues lining the channel walls are mainly hydrophobic, which make it suitable for 
diffusion of O2. However, the channel is of non-uniform diameter, where the narrowest span may 
require conformational isomerization of amino acid side chains for O2 to diffuse through. The channel 
extends in the plane of the membrane roughly to the level of the two hemes. The mouth of the channel 
is situated between transmembrane helices IV and V in subunit I, in a cleft formed by the two helix 
bundles of subunit III, and near the ends of the fatty acid side chains of a phosphatidyl choline 
molecule proposed to be bound in the cleft (Iwata et al., 1995). The possible role for subunit III and 
the bound lipid could be to facilitate O2 diffusion into the channel in subunit I (paper I). Subunit III 
could also prevent the obstruction of the mouth of the channel by other proteins in the membrane. 
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Figure 9. The putative O2 channel in subunit I of P. denitrificans cytochrome aa3 as viewed from the 
outside of the membrane along the membrane normal. The figure shows some amino acid residues lining 
the channel (numbering of amino acids refers to the cytochrome aa3 of P. denitrificans), the 
transmembrane helices of subunit I and the redox active metal centers. The figure was produced using 
the program Insight II (Version 97.0 Molecular Modeling System, Molecular Modeling Simulations Inc., 
1997). 
To investigate this putative channel, we performed a site-specific mutagenesis study in cytochrome 
bo3 of E. coli (paper I). Residues lining the channel were systematically substituted with those 
possessing larger side chains in order to sterically block the channel (Table 2). The change of an 
invariant valine 287 (Val243) to isoleucine raised the KM,app for O2 10-15 fold compared to the wild 
type enzyme, but did not change the steady state quinol-oxidizing activity. This result is expected 
when the channel is partially blocked. When an isoleucine side chain was modelled at the location of 
the native valine, the most probable rotamer would interfere with O2 diffusion into the binuclear site. In 
order to directly study the kinetics of O2 binding and the electron transfer reactions, the valine to 
isoleucine substitution was replicated in cytochrome aa3 of P. denitrificans (paper II). For this 
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mutant enzyme the KM,app for O2 was raised about 8 fold and the Vmax was decreased 50% compared 
to the wild type Paracoccus enzyme (paper II). 
Table 2. The K
M,app
 for O2 and Vmax of mutant enzymes in subunit I of  E. coli cytochrome bo3
.
 a
 The 
ubiquinol oxidase activity. b Mutant does not fit to one KM and Vmax solution. Numbering of amino 
acids refers to the cytochrome bo3 of E. coli. 
Mutant Aerobic 
growth 
KM,app  
for O2 
(mM)  
aVmax 
(% wt) 
Mutant Aerobic 
growth 
KM,app  
for O2 
(mM)  
aVmax 
(% wt) 
WT + 7 100 L246Y + 5 75 
I111F + 14 75 L246I + 7 100 
F112W + 6 80 V250Y + 7 100 
F112C + 4 60 V250W + 6 90 
F112Y + 6 100 I279W + 7 100 
W170F + 8 50 W280F - 6 b 3 
W170Q - 5 b 20 W280I - 2 b 4 
W170Y - 3 b 10 W282Y - 3 20 
L171W + 5 60 W282Q - 5 30 
L194F + 7 70 E286D + 5 30 
L194W + 7 75 E286C + 3 10 
F194Y + 5 75 E286Q - 2 b 5 
F194C + 7 100 V287T + 7 60 
F194I + 7 100 V287I + 60-120 100 
G198A + 6 100 V287L - 4 b 1 
G198I + 7 100 V287E - 5 b 1 
G198Q + 7 100 V287A - 5 1 
G198S + 7 100 L290F + 4 50 
G198W + 6 100 L290W - 8 20 
F243W + 7 100 L290I + 10 60 
L246F + 6 100 I424F + 35 70 
L246W + 6 100     
Mutant Aerobic  
growth 
K
M,app  
for O2 
(mM)  
aV
max 
(% wt) 
F112W / I279W + 6 60 
F112W / L194F / L246F + 4 60 
L171W / I279W + 10 75 
L194F / L246F + 6 50 
L194W / L246F + 8 60 
L194F / L246W + 8 70 
L194W / L246W - 3 25 
F243W / V250W  + 6 70 
 
 
The kinetics of O2 binding to the binuclear site as well as the subsequent reaction steps in the 
reduction of O2 to water can be studied by using the "flow-flash" method developed originally by 
Gibson and Greenwood (1963). In this method the fully, four electrons, reduced enzyme or the two 
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electron reduced enzyme which has CO bound to Fea3 is mixed with O2 in the dark. When the bound 
CO is photodissociated with a laser flash, O2 can bind to the binuclear site and the catalytic reaction is 
initiated. The reaction kinetics can then be followed e.g. by optical spectroscopy. The experiment may 
also be performed at low temperatures to slow down the reaction rate.  
In the Val279Ile (Val243) mutant enzyme the rate of initial binding of O2 to Fea3, i.e. the rate of 
formation of the ferrous-oxy intermediate A, decreased about 30 fold compared to the rate in the 
wild-type enzyme (paper II). This result implies that in the Val279Ile (Val243) mutant enzyme O2  
binding is slow and indicates that the isoleucine side chain interferes with the binding of O2 to the Fea3. 
Surprisingly, all the following reaction steps were also slowed down, which explained why the 
accumulation of the intermediate A was observed in the first place. These additional effects can not be 
explained by simple inhibition of O2 diffusion into the binuclear site (see chapter 5.2).  
An increase in the KM,app for O2, without an accompanying dramatic effect on Vmax can also be 
expected if electron transfer from heme a to heme a3 is inhibited. It is known that O2 binding to the 
Fea3 is very weak (the Kd is about 0.3 mM) and that it dissociates readily. The weak O2 binding to 
Fea3 is compensated by the kinetic trapping of O2 by a fast electron transfer between the heme 
groups. When this inter-heme electron transfer is slowed down, there is a proportional increase in 
KM,app for O2 (Verkhovsky et al., 1996). Since the native valine is situated close to heme a3, the 
bigger isoleucine side chain could slightly perturb the heme and slow down the inter-heme electron 
transfer.  
An electron "backflow" method can be used to directly study the rate of the above-mentioned 
electron transfer reaction. In this method CO bound to the two electron reduced (mixed valence) 
enzyme is photodissociated under anaerobic conditions, whereupon electrons at the binuclear site 
redistribute to previously oxidized metal centers (Verkhovsky et al., 1992). The electron redistribution 
consists of at least two phases. In the fast phase (with a time constant of 3-5 ms) electrons are 
transferred from Fea3 to Fea and in the slower phase (with a time constant of 35-50 ms) electron 
transfer occurs from an Fea3«Fea equilibrium to CuA. Our results showed that the fast phase of the 
electron transfer is not influenced by the Val279Ile (Val243) mutation. This means that O2 is efficiently 
trapped in the mutant enzyme (paper II) and the increase in KM,app for O2 is not due to a decreased 
inter-heme electron transfer rate. 
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The binding kinetics of CO after its photodissociation from Fea3 can be followed under anaerobic 
conditions to study the diffusion of CO inside the enzyme and binding of CO to the binuclear site. 
When CO dissociates from the Fea3, it transiently binds to CuB and then equilibrates with the external 
medium. Only after bulk medium equilibration does CO reenter the enzyme and transiently binds, first 
to CuB and then, more stabily, to Fea3 (Woodruff, 1993; Lemon et al., 1993). In the Val279Ile 
(Val243) mutant enzyme the kinetics of CO recombination were only slightly slower compared to the 
wild type enzyme (paper II). The wild type enzyme exhibits one main phase of CO recombination to 
Fea3. Interestingly, in the Val287Ile (Val243) cytochrome bo3 mutant enzyme from E. coli, the single 
recombination phase is replaced by two phases of roughly equal amplitude (Puustinen, unpublished 
observations). The fast phase exhibits saturation kinetics but the slow phase, does not saturate at the 
CO concentrations tested. This result indicates the presence of two different rotamers of the 
isoleucine side chain (see below). 
Light-minus-dark FTIR difference spectroscopy can be used to closely study the Fea3–CO and CuB–
CO structures in cytochrome c oxidase (Alben et al., 1981). In the FTIR difference spectrum of the 
Val287Ile (Val243) cytochrome bo3 mutant enzyme from E. coli two different Feo3–CO stretching 
frequencies at 1964 cm-1 and 1952 cm-1 have been observed instead of one at 1960 cm-1 (Puustinen, 
unpublished observations). Also the CuB–CO stretching band is slightly shifted from that of the wild 
type at 2065 cm-1. Similar results were obtained with the corresponding mutant enzyme from P. 
denitrificans (paper II). The results from the CO recombination experiments and the FTIR 
spectroscopy indicate the presence of two possible rotamers for the isoleucine side chain. For one 
possible rotamer the entry of CO to the binuclear site is hindered. For the second possible rotamer, 
CO enters freely but the isoleucine side chain, located very close to the binuclear site, slightly perturbs 
the site.  
The raised KM,app for O2 in theVal279Ile (Val243) mutant enzyme could also be related to the fact 
that the isoleucine side chain is situated in the immediate vicinity of the two metals of the binuclear site 
and could thus interfere directly with O2 binding to the Fea3. The present data do not allow us to 
exclude this possibility.  
As mentioned earlier, substitutions of amino acid residues elsewhere in the channel were carried out to 
identify the putative Fea3 ligand pathway. However, only a few other cytochrome bo3 mutant enzymes 
showed a raised KM,app for O2 (Table 2). One of these mutants contained the Ile111Phe (Ile66) 
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substitution which is located in transmembrane helix II, close to Glu286 (Glu242), an important 
residue for the proton translocation mechanism (Svensson-Ek et al., 1996; Ädelroth et al., 1997; 
Verkhovskaya et al., 1997). This result renders possible the likely interference of the new 
phenylalanine side chain with the proton translocation activity of the enzyme. The other cytochrome 
bo3 mutant enzyme with raised KM,app for O2 was the Ile424Phe (Leu381) substitution of 
transmembrane helix X. This residue is very close to the binuclear site and therefore does not help to 
firmly assign this channel as a ligand diffusion pathway. The light-minus-dark FTIR difference spectra 
of the Ile111Phe (Ile66) and the Ile424Phe (Leu381) mutant enzymes have been measured and the 
both mutant enzymes exhibits wild type like Feo3–CO and CuB–CO stretching bands (Puustinen, 
unpublished observations).  
The mutagenesis results show that it was difficult to block the O2 diffusion channel. Most of the amino 
acid substitutions did not effect the diffusion of O2 to the binuclear site. There may exist several 
reasons for that. As mentioned earlier, this channel is relatively wide and lined with bulky residues. 
These properties create difficulties to introducing steric hindrance into the channel, even though there 
are more narrow sections in the channel. Furthermore, the position of any particular mutated side 
chain is not known. There might also be a branch in the middle of the channel as has been noticed in a 
later inspection of the electron density map of cytochrome aa3 from P. denitrificans (Iwata, personal 
communication). In addition, proteins are dynamic systems which structurally “breathe” and these 
internal fluctuations certainly have an influence on the ligand migration inside cytochrome c oxidase. 
Is there a need for facilitated O2 diffusion inside cytochrome c oxidase? Several facts support the 
existence of the studied diffusion pathway for O2. First, O2 is assumed to enter the enzyme from the 
membrane because it is more soluble in the lipid phase than in the hydrophilic environment. The 
channel is perfectly situated for O2 to enter from the membrane space. Secondly, the binuclear site is 
deeply buried in subunit I which is surrounded by the other three subunits and additionally, in the 
mammalian enzyme, by the ten nuclear encoded subunits. Interestingly, these additional subunits are 
situated so that they do not interfere with the opening of the channel. Thirdly, as described earlier, a 
Fea3 ligand enters the binuclear site by first binding to CuB and then to Fea3 (see chapter 2.3.1). This 
defined order of binding suggests that ligands diffuse inside the protein through one specific route. If 
there were multiple pathways to the binuclear site ligands could be expected to bind also directly to 
Fea3. Fourth, the mammalian enzyme in cells of different tissues, depending on the distance from a 
capillary, is often exposed to very low and heterogeneous concentrations of O2. In these extreme 
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conditions the existence of a fairly unrestricted diffusion path in order to achieve a fast delivery of O2 
to the binuclear site is of great importance.  
The rate of O2 binding to cytochrome c oxidase is fast. The apparent second order rate constant of 
O2 binding to the enzyme is about 1.0 x 108 M-1s-1, which is close to the diffusion controlled maximal 
rate (Babcock and Wikström, 1992). This rate is approximately ten times faster than O2 binding to 
most other hemoproteins (Babcock and Wikström, 1992). In hemoglobin and myoglobin there are no 
clear diffusion pathways for O2 and O2 diffusion is expected to depend only on the dynamics of the 
globin structure (Olson and Phillips, Jr., 1996). However, these proteins only bind and transport O2, 
they are much smaller in size and are usually exposed to higher concentrations of O2. Additionally, the 
O2 binding site in these proteins is situated relatively close to the protein surface. Therefore, these 
proteins do not necessarily need a specific ligand diffusion pathway. 
While one ligand diffusion pathway may lead easily to the binuclear site of cytochrome c oxidase, 
there may still be competing pathways. Tsukihara et al. (1996) have described three pathways for O2 
diffusion in the structure of cytochrome aa3 from bovine heart mitochondria. Interestingly, one of these 
pathways is analogous to the one we have studied in P. denitrificans and E. coli. Recently, this 
pathway has been also described in the structure of cytochrome ba3 from Thermus thermophilus 
(Soulimane et al., 2000). The fact that similar channel structures are found in both the bacterial and 
the mammalian enzyme is an important finding that strongly supports the existence of the channel.  
X-ray crystallographic studies can provide only a static structure of an enzyme. Therefore, molecular 
dynamic calculations have been used to simulate the transient motions of the enzyme structure. 
Hofacker and Schulten (1998) have investigated the transport of O2 inside cytochrome c oxidase by 
this method. For the purpose of the simulations, O2 has been initially placed either in the binuclear site 
or in hydrophobic cavity at some distance from the binuclear site. During the simulations O2 have 
favored one pathway to or from the binuclear site. Most importantly, this pathway is the same one we 
propose. All the results presented here provide good evidence for the existence of a primary O2 
diffusion pathway to the binuclear site in subunit I of cytochrome c oxidase.  
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5.2 The connection between the proton-conducting D-channel and 
the binuclear site  
In the proton conducting D-channel Asp124 (Asp91) is located at the beginning of the pathway 
where it provides important acidic character to attract protons (Fig. 8) (Wikström, 1998; see chapter 
2.4.2). From Asp124 (Asp91) the D-channel continues to Asn113 (Asn80), Asn131 (Asn98), 
Ser134 (Ser101) and finally to Ser193 (Ser157), which corresponds to Thr201 in cytochrome bo3 
from E. coli.  
Water molecules have been predicted to participate in the proton transport in cytochrome c oxidase. 
Some water molecules have been detected in both the bacterial and the mammalian enzyme structures 
(Tsukihara et al., 1996; Ostermeier et al., 1997). Based on the four subunit structure of cytochrome 
aa3 from P. denitrificans at 2.8 Å, Iwata et al. (1995) have predicted several solvent molecules that 
are at hydrogen-bonding distance and are leading from the D-channel to Glu278 (Glu242). 
Ostermeier et al. (1997) at slightly better resolution (2.7 Å) of the two-subunit structure of the same 
enzyme could firmly identify one solvent molecule. This water molecule is located a short distance 
from Glu278 (Glu242). Yoshikawa et al. (1996) have reported at least five water molecules. Those 
water molecules are hydrogen-bonded to residues in the D-channel in the structure of cytochrome aa3 
from bovine heart mitochondria at 2.8 Å resolution. 
The likely positions of the water molecules not crystallographically defined, can be modelled. We 
applied the statistical-mechanical “potentials-of-mean-force” (PMF) method to predict the locations 
of bound water molecules in the structure of cytochrome aa3 from bovine heart mitochondria (paper 
III) (Hummer et al., 1995; Oprea et al., 1997). These PMF calculations located several water 
molecules that bridge the amino acid residues in the D-channel. More recently Hofacker and Schulten 
(1998) have modelled the likely positions of the water molecules in the same crystal structure, and 
have found a similar chain of water molecules leading from Asp124 (Asp91) to Glu278 (Glu242). 
They have proposed that the D-channel is formed almost exclusively of a hydrogen-bonded chain of 
water molecules which are stabilized by the polar residues in the channel.  
To test the functioning of the predicted network of bound water molecules we set up mutagenic 
experiments to interrupt it specifically, by substituting the Thr201 (Ser157) in cytochrome bo3 from E. 
coli with a phenylalanine or a tryptophan (paper III). The corresponding Ser201 (Ser157) residue in 
cytochrome aa3 from R. sphaeroides has been substituted with an alanine but the proton translocation 
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of this mutant enzyme was not affected (Mitchell et al., 1996). The inserted alanine side chain is small 
and may not be able to interrupt the water chain. Proton translocation activity of the two mutant 
enzymes, Thr201Trp (Ser157) and Thr201Phe (Ser157), was measured both in spheroplasts and in 
proteoliposomes. The Thr201Trp (Ser157) mutant enzyme exhibited a wild-type H+/e- ratio of about 
two (one proton results from ubiquinol oxidation and one is translocated by the enzyme). However, in 
the Thr201Phe (Ser157) mutant enzyme this ratio was decreased to one, which indicated that proton 
pumping was decoupled from electron transfer. Both mutant enzymes exhibited lowered turnover 
(15% of the wild-type enzyme) but this level of activity was sufficient to enable measurement of the 
proton translocation activity. The modelling of likely positions of the substituted side chains in the 
structure of cytochrome aa3 from bovine heart mitochondria showed that the ring of the tryptophan 
side chain might be orientated perpendicular to the membrane and that the chain of water molecules 
can run beside this residue uninterrupted. However, a phenylalanine ring at this position might be 
situated parallel to the membrane in the D-channel and therefore could interrupt the water array. 
These proton pumping results strongly support the idea that water molecules participate in proton 
conduction in the D-channel. 
In both crystal structures the D-channel ends in a hydrophobic cavity in the middle of the protein. 
There is no obvious pathway for proton transfer from Ser193 (Ser157) at the end of the D-channel to 
Glu278 (Glu242) in the structure of Paracoccus cytochrome aa3 (Iwata et al., 1995). However, as 
mentioned above water molecules have been predicted to make this connection and the PMF method 
found three well-defined water molecules that connect the top of the D-channel to Glu278 (Glu242) 
by hydrogen bonding (paper III).  
Glutamic acid 278 (Glu242) is one of the best conserved residues in the heme-copper oxidases. 
Buried carboxylic acids are rare in proteins and they are expected to be functionally important. Due to 
this fact, Glu278 (Glu242) is likely to be an essential residue for the function of the enzyme 
(Svensson-Ek et al., 1996; Ädelroth et al., 1997). The Glu286Cys (Glu242) and the Glu286Asp 
(Glu242) E. coli cytochrome bo3 mutant enzymes have sufficient activity for direct proton 
translocation measurements. In the Glu278Cys (Glu242) mutant enzyme the proton translocation 
activity is inhibited (Verkhovskaya et al., 1997). A detailed analysis have shown that the oxygen 
reduction chemistry in this mutant enzyme as well as in the Glu286Gln (Glu242) mutant is inhibited 
after formation of intermediate P (Svensson-Ek et al., 1996; Verkhovskaya et al., 1997; Ädelroth et 
al., 1997). The reaction would stop at this reaction intermediate if proton pumping was impaired 
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because only the P ® F and F ® O conversions are coupled to proton translocation (Fig. 7) 
(Wikström, 1989). These results show that Glu278 (Glu242) is a key residue for the mechanism of 
proton translocation by cytochrome c oxidase. 
The pathway for protons into the binuclear site is not clear beyond Glu278 (Glu242). Puustinen et al. 
(1997) have shown using FTIR spectroscopy of the wild type as well as the Glu278Asp (Glu242) 
and Glu278Cys (Glu242) mutant cytochrome bo3 enzymes that there is an easily polarizable, through-
bond connectivity between Glu278 (Glu242) and one of the histidine ligands of CuB. One of their 
suggestions was that the connection is formed through a chain of water molecules between Glu278 
(Glu242) and His276 (His240). These water molecules are probably positionally disordered and 
therefore not visible in the crystal structures. Furthermore, they might form an ordered chain only 
transiently as needed during the catalytic cycle.  
The proposal that water molecules connect Glu278 (Glu242) and the binuclear site is also supported 
by PMF calculations which predicted that at least three water molecules could form a hydrogen-
bonded chain in the bovine enzyme (paper III). The water chain leads from the vicinity of the CuB 
ligand His326 (His291) towards Glu278 (Glu242). The predicted water chain does not reach all the 
way to Glu278 (Glu242) if this side chain is orientated as has been resolved in the two crystal 
structures. However, rotating the glutamic acid side chain around the Cb–Cg bond brings it within the 
hydrogen-bonding distance of the last water molecule in the chain.  
We next tested whether the side chain of Glu278 (Glu242) needs to rotate during proton translocation 
(paper III). Met116 (Met71) in cytochrome bo3 of E. coli was substituted with a lysine or an 
arginine. Met116 (Met71) is located near Glu286 (Glu242) and the aim of this mutation was to fix the 
position of Glu278 (Glu242) by forming an electrostatic interaction and/or a hydrogen bond between 
Glu286 (Glu242) and the new side chain. Both the Met116Lys (Met71) and the Met116Arg 
(Met71) mutant enzymes failed to translocate protons, whereas, the Glu286Asp/Met116Lys 
(Glu242/Met71) or the Glu286Asp/Met116Arg (Glu242/Met71) double mutants exhibited wild-type 
proton translocation activity. The latter result ruled out the possibility that the abolishment of proton 
pumping in the Met116Lys (Met71) and the Met116Arg (Met71) mutant enzymes is due to an 
unspecific secondary effect of the introduced, positively charged side chain. Subsequently, Pomès et 
al. (1998) and Hofacker and Schulten (1998) have performed molecular dynamics simulations to 
investigate the conformational isomerization of Glu278 (Glu242). Their calculations have shown that 
the rotational mechanism suggested above is thermodynamically and kinetically competent, which 
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strongly supports the prediction that in order to pick up protons from the D-channel and shuttle them 
to the binuclear site, the side chain of Glu278 (Glu242) needs to undergo a rotational isomerization. 
Glu278 (Glu242) is missing from the cbb3-type of cytochrome c oxidases and from some other 
enzymes among the heme-copper oxidases which are known to translocate protons. One cytochrome 
c oxidase lacking Glu278 (Glu242) is cytochrome caa3 from Rhodothermus marinus. Homology 
modelling of R. marinus caa3 have found that a tyrosine residue occupies a similar spatial position as 
Glu278 (Glu242) (Pereira et al., 1999a). A tyrosine residue at this position is common for several 
oxidases which lack the glutamate residue. Based on this data, it has been suggested by Pereira et al. 
(1999a), that this tyrosine could replace the glutamic acid residue and connect the D-pathway to the 
binuclear site and participate the proton translocation in these enzymes. This suggestion has been later 
confirmed by demonstrating that this enzyme operates as a proton pump when reconstituted into 
liposomes (Pereira et al., 1999b). The structural theme of the region in the vicinity of the tyrosine in R. 
marinus caa3  has been mimicked in cytochrome aa3 from P. denitrificans to determine whether the 
Glu278 (Glu242) could be replaced by the amino acid residues of the R. marinus enzyme. Results of 
the site-specific mutagenesis study combined with molecular dynamic simulations have shown that this 
tyrosine residue and a carbonyl oxygen of a nearby serine may stabilise the long and only transiently 
forming water chain in this region, which continues from the D-channel to the CuB ligating His326 
(His291) (Backgren et al., 2000). The role of the tyrosine, stabilising one long water chain, is different 
from that of the Glu278 (Glu242) which shuttles protons between two short water chains and most 
probably functions as a true proton donor and acceptor.  
As described in the chapter 5.1, in the Val279Ile (Val243) mutant enzyme the binding of O2 to form 
the intermediate A was slowed down in addition to the slower rate of the following reaction steps 
(paper II). Since Val279 (Val243) lies very close to the oxygen reduction site, the introduced 
isoleucine side chain may disturb the formation of an ordered water chain from Glu278 (Glu242) to 
the binuclear site.  The protons in this ordered water chain would most likely be utilised in water 
formation because the mutant enzyme pumps protons with the same efficiency as the wild type. 
Furthermore, the isoleucine side chain may displace a water molecule which has been suggested to be 
weakly associated with CuB and to be essential in O-O bond splitting reaction (Ralle et al., 1999, 
Wikström 2000, Blomberg et al., 2000). These effects could explain the slow rate of the reaction 
steps beyond the intermediate P (paper II). 
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5.3 The new metal binding site in subunit I 
In isolated rat liver mitochondria an ATP induced proton electrochemical gradient has been shown to 
induce a 1-2 nm red shift in the optical absorption spectrum of heme a (Wikström et al., 1970; 
Wikström, 1972; 1974). Wikström and Saari (1975) have showed that Ca2+ induces a similar shift, 
when added to uncoupled mitochondria, sub-mitochondrial particles and isolated cytochrome aa3. 
Protons have been also shown to induce this spectral change (Saari et al., 1980). The mechanism of 
the shift has been attributed to interaction of Ca2+ and H+ with the propionates of heme a. This result 
is based on experiments using bis-imidazole heme A as the model compound (Saari et al., 1980). 
Ca2+ shifts the spectrum of bis-imidazole heme A to the red analogously with the effect of Ca2+ on the 
spectrum of heme a. This shift is prevented by methylation of the propionate carboxyls. The pKa of 
the group proposed to bind Ca2+ or H+ in cytochrome aa3 has been titrated to be of the order of 5.8-
6.2 pH units, which is the pKa range expected for porphyrin dicarboxylic acids. Therefore, it has been 
suggested that the propionate side chains of heme a are accessible to Ca2+ and H+ from the outside of 
the membrane (Saari et al., 1980).  
In further studies the specificity of the red shift has been tested but ions other than Ca2+ and H+ do not 
induce the shift (Saari et al., 1980). Mkrtchyan et al. (1990) have found that the red shift could be 
reversed and even inhibited by Na+, but that Na+ was not able to induce the shift itself. Kirichenko et 
al. (1998) have shown that the red shift is specific for the mammalian enzyme and is not observed in 
cytochrome c oxidase from R. sphaeroides or Saccharomyces cerevisiae.  
A previously unknown non-redox-active metal binding site have been determined in subunit I of 
cytochrome aa3 from both P. denitrificans and bovine heart mitochondria (Ostermeier et al., 1997; 
Yoshikawa et al., 1998). The chemical identity of the bound metal is unclear. In the Paracoccus 
enzyme the site is proposed to bind Ca2+ and in the bovine enzyme Na+. This metal binding site is 
situated in subunit I close to the outside surface of the protein. The site is formed by residues on the 
top of the transmembrane helix I and in the loop following it, with possible additional metal ligand 
residues from the loop between the transmembrane helices XI and XII (Fig. 10). Ostermeier et al. 
(1997) have reported five metal binding ligands in the Paracoccus enzyme, which are the backbone 
carbonyl oxygens of Glu56 (Glu40), His59 (Gln43) and Gly61 (Gly45) and the side chain oxygens of 
Glu56 (Glu40) and Gln63 (the loop where this residue is situated is missing from the bovine enzyme). 
Yoshikawa et al. (1998) have found the backbone carbonyl oxygens of Glu40, Gly45 and Ser441 as 
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well as a water molecule and the side chain carboxyl of Glu40 as ligands for the metal in the bovine 
enzyme.  
D477
Y478
Q63
I476
H59
G61
E56
 
Figure 10. The Ca2+ binding site in subunit I of P. denitrificans cytochrome aa3. The two main 
structures of the binding site are shown (see text). The ribbon shows the path of the protein 
backbone. Amino acid side chains involved in the binding of the metal are marked  (numbering of 
amino acids refers to the cytochrome aa3 of P. denitrificans). The figure was produced using the 
program MolScript (Kraulis 1991). 
Kirichenko et al. (1998) first noticed that the Ca2+-induced red shift of the optical spectrum of heme a 
in cytochrome aa3 from bovine heart mitochondria could be the result of Ca2+ binding to this newly 
determined metal binding site. They have also suggested that possible dissimilarities in this metal 
binding site between the mammalian and bacterial enzymes could be responsible for their different 
response to Ca2+. 
To study the similarities and differences of this metal binding site in the mammalian and bacterial 
structures, Ca2+ was inserted into the structures, which were then energy-optimized (paper IV). 
Calculations predicted extra metal ligating residues in both structures in addition to those reported 
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earlier. These were the side chain oxygens of Asp442 and Tyr443 and the backbone oxygen of 
Gln43 in the bovine enzyme and the side chain oxygen of Asp477 (Asp442) in the Paracoccus 
enzyme. Residues which are important for the overall conformation of this site and which are the same 
in both structures were also identified. 
The most obvious difference between the bacterial and mammalian metal binding sites is the side chain 
interaction of Gln63 in the Paracoccus enzyme. This residue is missing in the bovine enzyme but it is 
present in the cytochrome c oxidases from the R. sphaeroides and S. cerevisiae which similarly to 
the Paracoccus enzyme, do not exhibit a spectral shift (Kirichenko et al., 1998; see above). The 
Gln63Ala mutant enzyme exhibited the Ca2+-induced red shift of the optical spectrum of heme a 
(paper IV), which indicated that Gln63 may somehow shield the site and therefore the bound metal 
ion in the wild type Paracoccus enzyme is not dissociable. 
The second observed structural difference was a hydrogen bond between Asp442 in subunit I and 
Arg134 in subunit II in the bovine enzyme. This hydrogen bond could weaken the interaction of 
Asp442 with the metal ion and thus make the metal binding looser (paper IV). This interaction with 
subunit II is missing from the Paracoccus enzyme and may together with the Gln63 account for the 
difference in reactivity towards Ca2+ in cytochrome c oxidases. 
Glu56 (Glu40) was substituted with a glutamine or an alanine, and both the Glu56Gln and the 
Glu56Ala mutant enzymes exhibited the red shift (paper IV). A conservative substitution of Glu56 
(Glu40) with an aspartic acid resulted a mutant enzyme which showed negligible shift. The measured 
Kd for Ca2+ in the Glu56Gln (Glu40) mutant enzyme was 100 mM, which is higher than the Kd of 1.3 
mM reported for the bovine enzyme (Kirichenko et al., 1998). We also noticed that Na+ induces a 
similar but smaller spectral shift in the Glu56Gln (Glu40) mutant enzyme, with an apparent Kd of 270 
mM. Furthermore, Ca2+ and Na+ were observed to compete with each other for binding to this site in 
this mutant enzyme. Other cations, Li+, K+, Mg2+ and Mn2+, did not induce the shift at the 
concentrations tested. However, these metal ions reduced the size of the Ca2+-induced spectral shift 
when added prior to Ca2+. The Ca2+-induced shift in the Glu56Gln (Glu40) mutant enzyme was pH 
dependent. The size of the shift was reduced at low pH. This resembled the effect of pH on the Ca2+ -
induced shift in the bovine enzyme. However, the pKa value was higher in the Glu56Gln (Glu40) 
mutant enzyme. It was also noticed that the size of the Ca2+-induced spectral shift is smaller in the 
Paracoccus mutant enzymes than in the bovine. 
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As mentioned earlier, the chemical identity of the metal bound to the site in wild type Paracoccus and 
in the bovine enzyme is not known. The reduced minus oxidized difference spectrum of heme a in the 
Gln63Ala and the Glu56Ala (Glu40) mutant enzymes was blue shifted relative to wild type enzyme. 
For the Glu56Gln (Glu40) and the Glu56Asp (Glu40) mutant enzymes, addition of Ca2+ shifted the 
spectrum of heme a to red further than the wild type enzyme, which suggests that there may be Na+ 
bound in the native Paracoccus enzyme in conditions used in this study (paper IV).  
In the refined crystal structure of the Paracoccus enzyme a water molecule has been found as a sixth 
metal ligand in addition to the five amino acid residues previously described and this water molecule is 
in contact with Asp477 (Asp442) (Pfitzner et al., 1999). Mutation to substitute Asp477 (Asp442) 
with an alanine, have showed that the Asp477Ala (Asp442) mutant enzyme exhibited the Ca2+-
induced red shift. The metal composition analysis of the bovine and wild type Paracoccus enzyme by 
total-reflection X-ray fluorescence spectrometry have showed substoichiometric amounts of Ca2+ in 
the former enzyme and one Ca2+ per enzyme in the latter (Pfitzner et al., 1999). 
Based on the results it can be concluded that the new metal binding site found in the two cytochrome 
c oxidase structures is the site through which binding of Ca2+ or Na+ (or H+) shifts the spectrum of 
heme a. The two main differences in the structures of the metal sites in the Paracoccus and in the 
bovine enzyme described above probably influence the strength of the metal binding. Weaker binding 
in the bovine enzyme allows Ca2+ to dissociate. Whereas, in the Paracoccus enzyme the metal is not 
removable and the Ca2+ induced spectral shift is not observed.  
The structural and functional role of the metal binding site is not known. In all of the mutant enzymes 
made, proton translocation and oxygen consumption activities were as in the wild type enzyme 
suggesting that the site is not required directly for enzymatic activity. From the sequence alignment it 
was observed that all the metal ligating residues are missing from the quinol oxidizing cytochrome bo3 
of E. coli (paper IV), and Ca2+ does not induce the spectral shift (Puustinen, unpublished 
observation). Therefore a possible role for Ca2+ could be connected with the electron transfer from 
CuA to heme a. Alternatively, it might have a structural role in subunit I. Such a role has been 
suggested for Mn2+(Mg2+) which is also found only in cytochrome c oxidases (see chapter 2.2.2; 
Hosler et al., 1995; Mills and Ferguson-Miller, 1998). In the literature Ca2+ has been reported to 
increase thermostability and resistance to proteolysis (Kretsinger, 1976). Ca2+ is also a well-known 
activator and modulator of enzyme activity. It is possible that Ca2+ has a regulatory role in control of 
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the enzymatic activity of the mammalian cytochrome c oxidase. Bacteria can express different terminal 
oxidases depending on the environmental conditions and the energy need and, therefore, an extra 
regulatory factor may not be needed. 
As mentioned above this newly elucidated metal binding site is basically formed by the two main 
structures: the top of transmembrane helix I and the loop following it plus the loop connecting the 
transmembrane helices XI and XII. Binding of Ca2+ to this site in the bovine enzyme or in the 
Paracoccus mutant enzymes may induce conformational changes in one or both of these structures 
and/or change the conformation of the structures relative each other. Such a conformational change 
would then be conveyed to heme a. Monovalent Na+ may also bind to the bovine site but appears not 
to be able to induce the conformational change(s) needed to induce a spectral red shift of heme a.  
The conformational change at the metal binding site could be relayed to heme a via two possible 
pathways (paper IV). The shift could be exerted via the D-propionate group of heme a. The loop 
between the transmembrane helices XI and XII contains, in addition to the metal ligands, two 
conserved arginines of which Arg474 (Arg439) is making a hydrogen bond to the D-propionate 
group of heme a. Strengthening of this hydrogen bond due to a conformational change at the metal 
binding site could cause the red shift in the optical spectrum of heme a. To test the possibility of this 
idea Arg474 (Arg439) was substituted with an asparagine and this influenced the spectrum of heme a 
by shifting it to the blue. The second possible pathway includes Arg54 (Arg38) in helix I which has 
been suggested to form a hydrogen bond to the formyl group of heme a in P. denitrificans 
cytochrome aa3 (Iwata et al., 1995). This formyl group is conjugated to the heme a macrocycle and 
thus any change that strengthens this hydrogen bond would shift the spectrum of the heme a to the 
red. 
5.4 The optical absorption spectrum of cytochrome a 
Early spectroscopic studies by Callahan and Babcock (1983) and Babcock and Callahan (1983) 
showed that the optical spectrum of both ferric and ferrous heme a of the mitochondrial cytochrome c 
oxidase are red shifted about 18 nm compared to the isolated bis-imidazole heme A model 
compounds and the shift is pH dependent with a pKa of about 10.5. Additionally, in the resonance 
Raman spectrum, an abnormally low stretching frequency of the formyl carbonyl group compared to 
model heme A compounds was observed. These observations led to the interpretation that the 
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observed red shift of the heme a spectrum results from a hydrogen-bonding interaction between the 
formyl group and a nearby amino acid residue, which was suggested to be a tyrosine. 
Arginine 54 (Arg38) has been proposed to make a hydrogen bond to the formyl group of heme a in 
the structure of cytochrome aa3 from P. denitrificans (Iwata et al., 1995). The formyl group is 
conjugated to the macrocycle of heme a and because of this, a hydrogen-bonding interaction would 
influence the optical spectrum of heme a. This could explain why the reduced minus oxidized 
spectrum of heme a has a peak at 605 nm and not at 587 nm as in the isolated (bis-imidazole) heme 
A. To see if a change in the strength of this hydrogen bond could influence the optical spectrum of 
heme a and to find out whether this residue could be involved in the mechanism of the Ca2+ induced 
spectral shift of heme a, we substituted Arg54 (Arg38) with a glutamine or a methionine (paper V).  
The reduced minus oxidized absorption spectrum of heme a in wild type Paracoccus enzyme has a 
peak at 605 nm. This peak was shifted to 597 nm in the Arg54Gln (Arg38) mutant enzyme and to 
589 nm in the Arg54Met (Arg38) mutant enzyme (paper V). This type of blue shift in the optical 
spectrum of heme a is expected when the strength of the hydrogen bond between Arg54 (Arg38) and 
the formyl group of heme a is weakened. In the Arg54Met (Arg38) mutant enzyme the hydrogen 
bond to the formyl group of heme a is absent but the absorption peak did not shift completely to the 
position of the model heme A. The positively charged Arg474 (Arg439) is in hydrogen-bonding as 
well as in electrostatic interaction with the D-propionate of heme a (see chapter 5.3; Ostermeier et 
al., 1997; Kannt et al., 1998). This interaction has influence on the spectrum of heme a as was shown 
by substituting this residue with an asparagine (paper IV) and the interaction is still present in the 
Arg54Met (Arg38) mutant enzyme and is probably responsible for the rest of the red shift. 
Proton translocation activity was retained in the Arg54Gln (Arg38) mutant enzyme which exhibited 
25% of the wild type enzyme activity whereas, the enzymatic activity of the Arg54Met (Arg38) 
mutant enzyme was too low for multiturnover proton translocation measurements (paper V). 
However, this mutant was later shown to translocate protons (Backgren, unpublished observations). 
No indications of major perturbations of the binuclear site in these mutants were observed as binding 
of cyanide to Fea3 was similar in the mutants and in wild type. Yoshikawa et al. (1998) have 
suggested that Arg38 is part of a proton translocation pathway, which route is only found in 
cytochrome aa3 from bovine heart mitochondria and is not conserved in related enzymes from plant, 
yeast and bacteria. The strong indication that the mammalian and the bacterial enzymes operate by the 
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same mechanism, the site specific mutagenesis data by Lee et al. 2000, as well as proton pumping 
results above with Arg54 (Arg38) mutants do not support the idea that the suggested route is a 
functional proton translocation pathway. 
The strength of the hydrogen bond was shown to depend on the redox state of the iron, being 
stronger in the ferrous state (Callahan and Babcock 1983). During steady state respiration, heme a 
was reduced only 23 % and 18 % in the Arg54Gln (Arg38) and the Arg54Met (Arg38) mutant 
enzymes, respectively, compared to 40 % in wild type Paracoccus enzyme. This indicates that the 
low enzymatic activity of the mutant enzymes may be partly due to a decrease in the midpoint redox 
potential (Em) of heme a. Recently Kannt et al. (1999) measured the midpoint redox potential of 
heme a in the Arg54Met (Arg38) mutant enzyme and observed a significant decrease in it.  
Based on the results we conclude that the hydrogen bond between Arg54 (Arg38) and the formyl 
group of heme a is mainly responsible for the red shifted optical spectrum of heme a. Furthermore, 
we conclude that a possible conformational change induced by Ca2+ binding at the newly found metal 
binding site can be transmitted to heme a via transmembrane helix I by changing the strength of the 
hydrogen bond between Arg54 (Arg38) and the formyl group of heme a.  
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Summary  
The structures of cytochrome c oxidase from P. denitrificans and from bovine heart mitochondria 
are now known to the atomic level, however, the catalytic mechanism of this enzyme at the molecular 
level can not be deduced from the structure. The site-specific mutagenesis technique when combined 
with methods to analyze the effect of the mutations on the enzymes function is an important technique 
for study the mechanism of catalysis. The three dimensional structure is of great help when designing 
amino acid substitutions. 
In this work a possible channel for O2 diffusion into the binuclear site was found and the effect of the 
Val279Ile (Val243) mutation on ligand binding to Fea3 was studied in detail. Based on the results it 
was concluded that the isoleucine side chain at that position interferes with binding of O2 to Fea3. The 
proton conduction mechanism of the D-channel was shown to involve bound water molecules in 
addition to amino acid side chains. Glutamic acid 278 (Glu242), which is a key residue for proton 
conduction from the D-channel to the binuclear site may undergo conformational isomerization and 
water molecules may provide the connection from the end of the D-channel to Glu278 (Glu242) and 
from Glu278 (Glu242) to the binuclear site. The results of this work also showed that the newly 
defined non-redox-active metal binding site found in the bovine heart and P. denitrificans 
cytochrome c oxidase structures is the site through which binding of Ca2+ or Na+ (or H+) shifts the 
spectrum of heme a. Differences in the possible amino acid side chains available to ligate the metal ion 
of this site in the Paracoccus and in the bovine enzyme most likely influence the strength of the metal 
binding. This is one possible explanation as to why the Ca2+-induced spectral shift is observed with 
the bovine enzyme but not with wild type Paracoccus enzyme. The interaction of Arg54 (Arg38) with 
the formyl group of heme a was shown to be the reason behind the 18 nm shifted a-peak of 
cytochrome c oxidase compared to isolated heme A.  
Knowledge of the structure of the reaction cycle intermediates is needed to allow a detailed 
description of catalysis by cytochrome c oxidase. The determination of positions of the water 
molecules critical for proton translocation is one of the important aspects of future studies. One of the 
main questions to be answered is also, how proton pumping is coupled to the partial reactions within 
the reaction cycle. These important issues must be addressed in order to understand the mechanism of 
catalysis by cytochrome c oxidase. 
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